Skip to content

Azenta AZTA Rest of Europe — Long-Lived Assets

Other geography segments

Asia Pacific (Excluding China)
$3.15M
Other
$54K

Similar metrics at other companies

Trimas logo
TRSEurope — Long-Lived Assets
$237.02M+9.2%
Sabre logo
SABREurope — Long-Lived Assets
$17M-22.4%
Matthews International logo
MATWEurope — Long-Lived Assets
$108.88M-54.3%
Distribution Solutions Group, Inc. logo
DSGREurope — Long-Lived Assets
$30.81M+0.3%
AtriCure logo
ATRCEurope — Long-Lived Assets
$6.02M+6.1%
Atkore logo
ATKREurope — Long-Lived Assets
$48.69M-8.7%

Other financials

Income statement

See full
Revenue$144.8M+1.0%
Gross profit$62.0M-1.2%
Operating income-$165.8M-811%
Net income-$160.8M-237%
EPS (diluted)-$3.49-236%

Balance sheet

See full
Cash & equivalents$125.2M
Total debt$55.7M
Total equity$1.6B-8.3%
Total assets$1.9B

Cash flow

See full
Operating cash flow$13.5M-6.2%
CapEx$7.4M-0.1%
Free cash flow$6.1M-12.7%

Valuation

See full
Market cap$1.1B-19.0%
Enterprise value$1.03B
P/S1.8×-0.3×

Profitability

See full
Gross margin40%-1.0pp
Operating margin-31.6%-59.7pp
Net margin-29.1%-80.7pp
FCF margin8.6%

Returns & leverage

See full
Return on equity-10.7%-22.4pp
Debt / equity
Current ratio2.8×

Where this comes from

Reported directly by Azenta in its filing.

Tagged under the XBRL concept us-gaap:NoncurrentAssets.

The official record: Azenta’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Azenta's rest of europe — long-lived assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Azenta's rest of europe — long-lived assets?
Azenta (AZTA) reported rest of europe — long-lived assets of $15.27M in Q1 2026.
What does rest of europe — long-lived assets mean?
This metric measures the net book value of non-current, tangible, and intangible assets located within the specified European geographic region. These assets typically include property, plant, equipment, and other long-term investments essential for supporting cold-chain sample management and genomic service operations. It provides insight into the company's capital intensity and the physical infrastructure footprint maintained to serve the European market.